With a market cap of has a large market cap size. AbbVie Inc. (NYSE: ABBV) has been on the stock market since its IPO date on the 1/2/2013. AbbVie Inc. is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AbbVie Inc., is 7925.87, and so far today it has a volume of 5096700. Performance year to date since the 1/2/2013 is 11.24%.
To help you determine whether AbbVie Inc. is undervalued the following values will help you decide. P/E is 18.36 and forward P/E is 11.22. PEG perhaps more useful shows that AbbVie Inc. has a value for PEG of 1.13. P/S ratio is 4.22 and the P/B ratio is 18.45. The P/Cash and P/Free cash flow is 13.05 and 25.48 respectively.
At the current price AbbVie Inc. is trading at, 64.03 (-0.11% today), AbbVie Inc. has a dividend yield of 3.56%, and this is covered by a payout ratio of 63.30%. Earnings per share (EPS) is 3.49, and this is looking to grow in the next year to 18.66% after growing 185.20% this past year. EPS growth quarter over quarter is 17.90%, and 17.80% for sales growth quarter over quarter.
The number of shares outstanding is 1631.32, and the number of shares float is 1627.2. The senior management bring insider ownership to 0.10%, and institutional ownership is at 71.90%. The float short is 2.95%, with the short ratio at a value of 6.06. Management has seen a return on assets of 10.00%, and also a return on investment of 16.90%.
The ability for AbbVie Inc., to deal with debt, means it current ratio is 1.8, and quick ratio is 1.6. Long term debt/equity is 6.62 and total debt/equity is 6.71. In terms of margins, AbbVie Inc. has a gross margin of 78.60%, with its operating margin at 35.00%, and AbbVie Inc. has a profit margin of 23.10%.
The 52 week high is -6.00%, with 44.99% being its 52 week low. The 20 day simple moving average is -0.51% and the 200 day simple moving average is 8.50%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.